{"id":"NCT03653026","sponsor":"AbbVie","briefTitle":"A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-06","primaryCompletion":"2021-01-14","completion":"2021-01-14","firstPosted":"2018-08-31","resultsPosted":"2021-11-26","lastUpdate":"2022-03-02"},"enrollment":522,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ulcerative Colitis (UC)"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Upadacitinib","otherNames":["ABT-494","RINVOQ®"]}],"arms":[{"label":"Upadacitinib 45 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission (per Adapted Mayo score) in participants with moderately to severely active ulcerative colitis (UC).","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Clinical Remission Per Adapted Mayo Score at Week 8","timeFrame":"Week 8","effectByArm":[{"arm":"Upadacitinib 45 mg","deltaMin":33.5,"sd":null},{"arm":"Placebo","deltaMin":4.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":379,"countries":["United States","Argentina","Australia","Austria","Belgium","Bosnia and Herzegovina","Brazil","Canada","Chile","China","Colombia","Croatia","Czechia","Estonia","Finland","France","Germany","Greece","Hungary","Ireland","Israel","Italy","Japan","Latvia","Lithuania","Malaysia","Mexico","Netherlands","Norway","Poland","Portugal","Puerto Rico","Russia","Serbia","Singapore","Slovakia","South Africa","South Korea","Spain","Switzerland","Taiwan","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40488552","38010661","37942921","36790041","36645051","36571701","36464141","35644166"],"seeAlso":["https://www.rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":344},"commonTop":["ACNE","HEADACHE","BLOOD CREATINE PHOSPHOKINASE INCREASED","PYREXIA","ANAEMIA"]}}